Showing results (201-210 of 757) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|March 11, 2022
Roles of the gut virome and mycobiome in faecal microbiota transplantationSiu Lam, Xiaowu Bai, Andrey N Shkoporov, et al.
The Lancet. Gastroenterology & Hepatology|January 23, 2022
Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn's disease (ProtDilat study): an open-label, multicentre, randomised trialCarme Loras, Xavier Andújar, Joan B Gornals, et al.
The Lancet. Gastroenterology & Hepatology|January 9, 2023
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver diseaseGiovanni Targher, Alessandro Mantovani, Christopher D Byrne
The Lancet. Gastroenterology & Hepatology|December 15, 2022
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose studyRohit Loomba, Eric J Lawitz, Juan Pablo Frias, et al.
The Lancet. Gastroenterology & Hepatology|December 17, 2022
Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort studyManuel Luis Rodríguez-Perálvarez, Antonio Manuel Gómez-Orellana, Avik Majumdar, et al.
The Lancet. Gastroenterology & Hepatology|May 15, 2020
Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysisRen Mao, Yun Qiu, Jin-Shen He, et al.
The Lancet. Gastroenterology & Hepatology|May 12, 2020
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label studyJordan J Feld, Marcelo Cypel, Deepali Kumar, et al.
The Lancet. Gastroenterology & Hepatology|October 26, 2019
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Gastroenterology & Hepatology|October 26, 2019
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Gastroenterology & Hepatology|May 9, 2021
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort studyBehzad Hajarizadeh, Jason Grebely, Marianne Byrne, et al.
Pageof 76